WJ-MSCs

mesenchymal stromal cells from Wharton's jelly

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for WJ-MSCs, covering 2024-03-12 to 2024-03-12. Get the full timeline:

Most recent: Clinical Trial Update: Sequential Administration of WJ-MSCs for the Treatment of GvHD Refractory to Second Line Treatment [Phase 1, Phase 2]

See pricing